https://www.sciencedirect.com/science/article/pii/S1473309921004850
The negative French Randomized Controlled Trial on Remdesivir (n=857)
"No clinical benefit observed from the use of remdesivir in hospitalised patients, symptomatic for more than 7 days, on oxygen support."
The negative French Randomized Controlled Trial on Remdesivir (n=857)
"No clinical benefit observed from the use of remdesivir in hospitalised patients, symptomatic for more than 7 days, on oxygen support."
COVID-19 Vaccine Excipients table
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857113/table/tbl1/?report=objectonly
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857113/table/tbl1/?report=objectonly
PubMed Central (PMC)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
Vaccines against COVID-19 (and its emerging variants) are an essential global intervention to control the current pandemic situation. Vaccines often cause adverse events; however, the vast majority of adverse events following immunization (AEFI) are a ...
COVID-19 Vaccine Excipients table
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857113/table/tbl1/?report=objectonly
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857113/table/tbl1/?report=objectonly
This media is not supported in your browser
VIEW IN TELEGRAM
RN speaks out about the ineffectiveness and physiological consequences of prolonged mask-wearing.
https://genetherapynetwork.com/gene-therapy-safety/overview-viral-vector-shedding/ this relates to adenovirus vector vaccines from J&J and AstraZeneca (India)
Gene Therapy Network
Overview Viral Vector Shedding | Gene Therapy Network
Overview of Viral Vector Shedding Vector shedding is the release of virus-based gene therapy products from the patient through one or all of the following routes: excreta (feces), secreta (urine, saliva, nasopharyngeal fluids, etc.), and skin (pustule, sores…